Orchestra BioMed Holdings, Inc. (OBIO)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 01:14PM EDT. Market open.
| Previous close | 5.21 |
| Open | 5.36 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 5.07 - 5.36 |
| 52-week range | 4.22 - 17.35 |
| Volume | |
| Avg. volume | 40,212 |
| Market cap | 184.311M |
| Beta (5Y monthly) | 0.22 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of 5% and 51.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Orchestra BioMed Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Orchestra BioMed Holdings ( NASDAQ:OBIO ) Full Year 2023 Results Key Financial Results Net loss: US$49.1m (loss widened...
- Zacks
Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season
Orchestra BioMed (OBIO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
© 2024 Yahoo. All rights reserved.